Solid Biotech Co. is specialized in quasi-drugs and medical devices since its establishment in May 2020, with the purpose of manufacturing quasi-drugs (masks), consignment production of medical devices (diagnostic kits), and sales of medical devices.

The in vitro diagnostic reagent sector is a high value-added industry with an annual market growth rate of 23%, which is expected to be a business area where Korean bio ventures can have sufficient international competitiveness in that ideas and biotechnology application marketing skills are prioritized over other bio industries that require long technology accumulation.

We, Solid Biotech, are responsible for optimal consignment manufacturing and quality with automated equipment, with experience in supplying automated devices to multinational diagnostic companies and developing original inspection methods, and are also preparing to sell medical devices simultaneously.

We currently have a distribution network in the field of quasi-drugs and medical devices, and are rapidly growing online and offline as the best customer-oriented items.